| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 06/24/2004 | US20040121345 Identification of a human n-terminal acetyltransferase gene |
| 06/24/2004 | US20040120957 Use of A33 antigens JAM-it |
| 06/24/2004 | US20040120945 Cell surface molecule mediating cell adhesion and signal transmission |
| 06/24/2004 | CA2508631A1 Regulatory zinc finger proteins |
| 06/24/2004 | CA2505870A1 Targeting single epitopes |
| 06/23/2004 | EP1430131A2 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 06/23/2004 | EP1430130A2 Nucleic acid-associated proteins |
| 06/23/2004 | EP1430083A2 T1r taste receptors and genes encoding same |
| 06/23/2004 | EP1430079A1 Fluorescent proteins |
| 06/23/2004 | EP1342730A4 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 06/23/2004 | EP1131411B1 Suppression of xenotransplant rejection |
| 06/23/2004 | EP0977861B1 Mammalian cytokine-like factor 7 |
| 06/23/2004 | EP0646176B1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 06/23/2004 | CN1506377A Human granulocyte-macrophage colony stimulating factor/interleukin-6 fusion protein and its construction process |
| 06/23/2004 | CN1154730C Compounds and methods for diagnosis of tuberculosis |
| 06/23/2004 | CN1154726C OB protein derivatives having prolonged half-life |
| 06/23/2004 | CN1154660C Hybrid molecules between heat-labile enterotoxin and cholera toxic B subunits |
| 06/22/2004 | US6753419 Used for somatic gene therapy |
| 06/22/2004 | US6753314 Protein-protein complexes and methods of using same |
| 06/22/2004 | US6753162 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 06/22/2004 | US6752996 Adjuvant for poorly immunogenic tumor vaccines and subunit vaccines, such as those for preventing and/or treating flu, tuberculosis, respiratory syncytial virus, anthrax and hiv. |
| 06/22/2004 | US6752995 Nucleic acid and polypeptide sequences useful as adjuvants |
| 06/22/2004 | CA2117904C Methods and reagents for diagnosis of autoantibodies |
| 06/17/2004 | WO2004050698A2 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 06/17/2004 | WO2004050692A2 Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production |
| 06/17/2004 | WO2003064992A3 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 06/17/2004 | WO2003059259A3 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 06/17/2004 | WO2002086443A8 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 06/17/2004 | US20040116662 Comprises viral glycoprotein fusion with glutathione s-tranferase (GST) or thioredoxin for use as diagnostic tool in screening blood products for retroviral infection |
| 06/17/2004 | US20040116369 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 06/17/2004 | US20040115220 Vaccine |
| 06/17/2004 | US20040115202 monospecific antibody which specifically binds an epitope of a mammalian DPPIV (dipeptidyl peptidase IV, also known as CD26). |
| 06/17/2004 | US20040115184 Methods and compositions for modifying apolipoprotein b mrna editing |
| 06/16/2004 | EP1427837A2 Modular transfection systems |
| 06/16/2004 | EP1427827A2 Synthetic hcv envelope proteins and their use for vaccination |
| 06/16/2004 | EP1427758A2 Compositions and methods of treating diabetes |
| 06/16/2004 | EP1427751A2 Trk polypeptide purification method |
| 06/16/2004 | EP1427750A1 Modified transferrin fusion proteins |
| 06/16/2004 | EP0580737B1 Heterodimeric receptor libraries using phagemids |
| 06/16/2004 | CN1505526A Compositions and methods for wt1 specific immunotherapy |
| 06/16/2004 | CN1504573A Confluent protein capable of self-cracking into polypeptide with antibiosis and reparation function |
| 06/15/2004 | US6750378 Maize H3C4 promoter combined with the first intron of rice actin, chimeric gene comprising it and transformed plant |
| 06/15/2004 | US6750194 Administering to the subject a safe and effective amount of a vpac receptor agonist selected from the group consisting of ro 25-1553, and pacap-38 |
| 06/10/2004 | WO2004047812A1 Hollow nanoparticles of protein and drug using the same |
| 06/10/2004 | WO2004047728A2 Compositions and methods for the treatment of immune related diseases |
| 06/10/2004 | WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/10/2004 | WO2003054142A3 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 06/10/2004 | US20040110941 by cloning, amplifying and expressing DNA sequences using polymerase chain reaction; for therapy, diagnosis or catalysis; solid phase synthesis |
| 06/10/2004 | US20040110935 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 06/10/2004 | US20040110690 Transporter peptide capable of translocating across biological membrane of pancreatic B-cells, hepatocytes, colon cells, muscle cells and/or lung cells; drug delivery; biochemical conjugation |
| 06/10/2004 | US20040110670 Heterologous expression of neisserial proteins |
| 06/10/2004 | US20040110218 BMOG, a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for immunomodulatory purposes |
| 06/10/2004 | US20040110181 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040109871 Gene, immunogen transfer ; induction mucous membrane immunity; polynucleotide sequences ; bactericides, viricides, fungicides, parasirtici des, anticancer agents |
| 06/10/2004 | CA2504144A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 06/09/2004 | EP1425409A2 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 06/09/2004 | EP1425302A2 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 06/09/2004 | EP1425042A1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 06/09/2004 | EP1425036A2 Virus coat protein/receptor chimeras and methods of use |
| 06/09/2004 | CN1502697A Alzhimer's disease secretase |
| 06/09/2004 | CN1502696A Alzheimer's disease secretase |
| 06/09/2004 | CN1502692A Alzheimer's disease secretase |
| 06/09/2004 | CN1502632A Novel TNFR-FC fusion protein |
| 06/09/2004 | CN1502631A Carcino-embryonic untigen specific combined peptide and fusion protein with TNF-alpha |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/08/2004 | CA2064814C Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 06/03/2004 | WO2004016283A3 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 06/03/2004 | WO2003095493A3 Toxin-related antibodies with antimicrobial and antiviral activity |
| 06/03/2004 | WO2003089475A3 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 06/03/2004 | WO2003089450A3 Fusion polypeptides and methods for inhibiting microbial adhesion |
| 06/03/2004 | WO2003088995A3 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 06/03/2004 | US20040106777 Comprises nucleotide sequences coding extracelular matrix interacting protein for screening and identifying modulators and treatment for cancers and arteriosclerosis; tissue engineering |
| 06/03/2004 | US20040106544 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements |
| 06/03/2004 | US20040106154 In vivo screen using chemical inducers of dimerization |
| 06/03/2004 | US20040106149 Novel gpcr hfrbn63 |
| 06/03/2004 | US20040106134 Comprises genetically engineered immunoglobulin for use in the treatment of bone disorders |
| 06/02/2004 | EP1424343A1 Peptide Conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423527A1 System for detecting protease |
| 06/02/2004 | EP1423524A2 Method of protein production in plants |
| 06/02/2004 | EP1423519A2 G-protein coupled receptor and dna sequences thereof |
| 06/02/2004 | EP1423510A2 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 06/02/2004 | EP1423427A2 Nogo receptor homologues and their use |
| 06/02/2004 | EP1423424A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
| 06/02/2004 | EP1423419A2 Hybrid and tandem expression of neisserial proteins |
| 06/02/2004 | EP1423002A1 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent |
| 06/02/2004 | EP0981541B1 Psca: prostate stem cell antigen |
| 06/02/2004 | EP0941334B1 Protease-activatable pseudomonas exotoxin a-like proproteins |
| 06/02/2004 | CN1500820A Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 06/02/2004 | CN1500811A Confluent protein of human interferon and human IgGFc variant without cracking ability and preparing method thereof |
| 06/02/2004 | CN1151799C Bacterial membrane fractions with adjuvant effect |
| 06/01/2004 | US6743908 For use in cancer diagnosis and therapy |
| 06/01/2004 | US6743896 Protien for use in the treatment of infection and tumors |
| 06/01/2004 | CA2034034C Process for the production of antibodies |
| 05/27/2004 | WO2004044008A1 Dna/rna transduction technology and its clinical and basic applications |
| 05/27/2004 | WO2004043981A2 Nucleic acids and proteins with thioredoxin reductase activity |
| 05/27/2004 | WO2003004604A3 Phage displayed pdz domain ligands |
| 05/27/2004 | WO2002060480A9 Methods for treating or preventing skin disorders using cd2-binding agents |